⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 21, 2015Journal of Clinical InvestigationOpen Access

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Lisa Rice Cristina M. Padilla Sarah McLaughlin Allison L. Mathes Jessica Ziemek Salma Goummih Sashidhar Nakerakanti Michael York Giuseppina Farina Michael L. Whitfield Robert Spiera Romy Christmann Jessica Gordon Janice Weinberg Robert W. Simms Robert Lafyatis

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Clinicaltrials.gov NCT01284322.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rice et al. (2015) studied this question.

synapsesocial.com/papers/69d7ee6c5c3030ff03d18562 https://doi.org/10.1172/jci77958

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Type beta transforming growth factor: a bifunctional regulator of cellular growth.Original Research · 1985 · 1,093 citations
2Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.In Vitro Study · 1986 · 2,868 citations
3Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.Original Research · 1988 · 415 citations
4Cyclophosphamide versus Placebo in Scleroderma Lung DiseaseRCT · 2006 · 1,675 citations
5Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisHuman Clinical Trial · 2014 · 762 citations

Cellular and molecular mechanisms of fibrosis2007
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial2000
Systemic sclerosis: a prototypic multisystem fibrotic disorder2007
Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation programJournal of Clinical Investigation · 2026
HIV reservoir cells do not show general resistance to effector molecules secreted by cytolytic T lymphocytesJournal of Clinical Investigation · 2026

More from Journal of Clinical Investigation

More from Boston University

More from Hospital for Special Surgery